Curis (CRIS) Payables (2010 - 2026)
Curis' (CRIS) quarterly Payables came in at $6.7 million in Q1 2026, up 32.09% YoY from $5.1 million in Q1 2025, and up 20.14% on a QoQ basis from $5.6 million in Q4 2025.
Curis (CRIS) Payables (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Payables data on file, last reported at $6.7 million in Q1 2026.
- Quarterly Payables rose 32.09% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 32.09% YoY) and the FY2025 annual result came in at $5.6 million, up 85.58% from the prior year.
- Payables rose to $6.7 million in Q1 2026, from $5.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $6.7 million in Q1 2026 to a low of $2.4 million in Q2 2024.
- A 5-year average of $4.2 million and a median of $4.1 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables sank 51.26% — and 2025, when it jumped 85.58%.
- Tracing CRIS's Payables over 5 years: stood at $3.2 million in 2022, then dropped by 0.66% to $3.2 million in 2023, then decreased by 4.67% to $3.0 million in 2024, then jumped by 85.58% to $5.6 million in 2025, then rose by 20.14% to $6.7 million in 2026.
- The last three Payables figures came in at $6.7 million (Q1 2026), $5.6 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Curis | 3.44 Mn | -2.18 Mn | - | 5.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 5.61 Mn |
| Sep 30, 2025 | 4.45 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 5.10 Mn |
| Dec 31, 2024 | 3.02 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 3.63 Mn |
| Dec 31, 2023 | 3.17 Mn |
| Sep 30, 2023 | 5.22 Mn |
| Jun 30, 2023 | 2.69 Mn |
| Mar 31, 2023 | 2.64 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 5.76 Mn |
| Jun 30, 2022 | 5.51 Mn |
| Mar 31, 2022 | 4.28 Mn |
| Dec 31, 2021 | 6.42 Mn |
| Sep 30, 2021 | 3.51 Mn |
| Jun 30, 2021 | 4.05 Mn |